These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29514097)

  • 1. Estrogen Deficiency Promotes Hepatic Steatosis via a Glucocorticoid Receptor-Dependent Mechanism in Mice.
    Quinn MA; Xu X; Ronfani M; Cidlowski JA
    Cell Rep; 2018 Mar; 22(10):2690-2701. PubMed ID: 29514097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice.
    Mueller KM; Kornfeld JW; Friedbichler K; Blaas L; Egger G; Esterbauer H; Hasselblatt P; Schlederer M; Haindl S; Wagner KU; Engblom D; Haemmerle G; Kratky D; Sexl V; Kenner L; Kozlov AV; Terracciano L; Zechner R; Schuetz G; Casanova E; Pospisilik JA; Heim MH; Moriggl R
    Hepatology; 2011 Oct; 54(4):1398-409. PubMed ID: 21725989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMPK regulates metabolic actions of glucocorticoids by phosphorylating the glucocorticoid receptor through p38 MAPK.
    Nader N; Ng SS; Lambrou GI; Pervanidou P; Wang Y; Chrousos GP; Kino T
    Mol Endocrinol; 2010 Sep; 24(9):1748-64. PubMed ID: 20660302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development.
    Mueller KM; Themanns M; Friedbichler K; Kornfeld JW; Esterbauer H; Tuckermann JP; Moriggl R
    Mol Cell Endocrinol; 2012 Sep; 361(1-2):1-11. PubMed ID: 22564914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid Induces Hepatic Steatosis by Inhibiting Activating Transcription Factor 3 (ATF3)/S100A9 Protein Signaling in Granulocytic Myeloid-derived Suppressor Cells.
    Liu YF; Wei JY; Shi MH; Jiang H; Zhou J
    J Biol Chem; 2016 Oct; 291(41):21771-21785. PubMed ID: 27573240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. REVERBa couples the circadian clock to hepatic glucocorticoid action.
    Caratti G; Iqbal M; Hunter L; Kim D; Wang P; Vonslow RM; Begley N; Tetley AJ; Woodburn JL; Pariollaud M; Maidstone R; Donaldson IJ; Zhang Z; Ince LM; Kitchen G; Baxter M; Poolman TM; Daniels DA; Stirling DR; Brocker C; Gonzalez F; Loudon AS; Bechtold DA; Rattray M; Matthews LC; Ray DW
    J Clin Invest; 2018 Oct; 128(10):4454-4471. PubMed ID: 30179226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E47 modulates hepatic glucocorticoid action.
    Hemmer MC; Wierer M; Schachtrup K; Downes M; Hübner N; Evans RM; Uhlenhaut NH
    Nat Commun; 2019 Jan; 10(1):306. PubMed ID: 30659202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
    Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
    Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The glucocorticoid receptor: cause of or cure for obesity?
    John K; Marino JS; Sanchez ER; Hinds TD
    Am J Physiol Endocrinol Metab; 2016 Feb; 310(4):E249-57. PubMed ID: 26714851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Glucocorticoid Receptor Modulation Prevents and Reverses Nonalcoholic Fatty Liver Disease in Male Mice.
    Koorneef LL; van den Heuvel JK; Kroon J; Boon MR; 't Hoen PAC; Hettne KM; van de Velde NM; Kolenbrander KB; Streefland TCM; Mol IM; Sips HCM; Kielbasa SM; Mei H; Belanoff JK; Pereira AM; Oosterveer MH; Hunt H; Rensen PCN; Meijer OC
    Endocrinology; 2018 Dec; 159(12):3925-3936. PubMed ID: 30321321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and voluntary exercise attenuate cardiometabolic syndrome and hepatic steatosis in ovariectomized rats fed a high-fat high-fructose diet.
    Buniam J; Chukijrungroat N; Khamphaya T; Weerachayaphorn J; Saengsirisuwan V
    Am J Physiol Endocrinol Metab; 2019 May; 316(5):E908-E921. PubMed ID: 30807216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The glucocorticoid receptor controls hepatic dyslipidemia through Hes1.
    Lemke U; Krones-Herzig A; Berriel Diaz M; Narvekar P; Ziegler A; Vegiopoulos A; Cato AC; Bohl S; Klingmüller U; Screaton RA; Müller-Decker K; Kersten S; Herzig S
    Cell Metab; 2008 Sep; 8(3):212-23. PubMed ID: 18762022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GR-mediated FTO transactivation induces lipid accumulation in hepatocytes via demethylation of m
    Hu Y; Feng Y; Zhang L; Jia Y; Cai D; Qian SB; Du M; Zhao R
    RNA Biol; 2020 Jul; 17(7):930-942. PubMed ID: 32116145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of Glucocorticoid Signaling.
    Vitellius G; Trabado S; Bouligand J; Delemer B; Lombès M
    Ann Endocrinol (Paris); 2018 Jun; 79(3):98-106. PubMed ID: 29685454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase.
    Gong H; Jarzynka MJ; Cole TJ; Lee JH; Wada T; Zhang B; Gao J; Song WC; DeFranco DB; Cheng SY; Xie W
    Cancer Res; 2008 Sep; 68(18):7386-93. PubMed ID: 18794126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follicle-stimulating hormone enhances hepatic gluconeogenesis by GRK2-mediated AMPK hyperphosphorylation at Ser485 in mice.
    Qi X; Guo Y; Song Y; Yu C; Zhao L; Fang L; Kong D; Zhao J; Gao L
    Diabetologia; 2018 May; 61(5):1180-1192. PubMed ID: 29442133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral 17beta-estradiol decreases fasting blood glucose levels in non-obese mice with short-term ovariectomy.
    Kim JY; Jo KJ; Kim OS; Kim BJ; Kang DW; Lee KH; Baik HW; Han MS; Lee SK
    Life Sci; 2010 Sep; 87(11-12):358-66. PubMed ID: 20655933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional ablation of mediator subunit MED1 (MED1/PPARBP) gene in mouse liver attenuates glucocorticoid receptor agonist dexamethasone-induced hepatic steatosis.
    Jia Y; Viswakarma N; Fu T; Yu S; Rao MS; Borensztajn J; Reddy JK
    Gene Expr; 2009; 14(5):291-306. PubMed ID: 19630272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicle-stimulating hormone promotes the transformation of cholesterol to estrogen in mouse adipose tissue.
    Cui H; Zhao G; Wen J; Tong W
    Biochem Biophys Res Commun; 2018 Jan; 495(3):2331-2337. PubMed ID: 29274780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipocyte GR Inhibits Healthy Adipose Expansion Through Multiple Mechanisms in Cushing Syndrome.
    Hayashi R; Okuno Y; Mukai K; Kitamura T; Hayakawa T; Onodera T; Murata M; Fukuhara A; Imamura R; Miyagawa Y; Nonomura N; Otsuki M; Shimomura I
    Endocrinology; 2019 Mar; 160(3):504-521. PubMed ID: 30649271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.